Phospho-NCF1 (S370) Antibody

Basic Research Questions

• What is the molecular function of NCF1 and why is S370 phosphorylation significant?

  NCF1 (p47-phox) is a cytosolic component of the NADPH oxidase complex that, along with NCF2 (p67-phox) and membrane-bound cytochrome b558, is required for activation of the latent NADPH oxidase. This enzyme complex is necessary for superoxide production in phagocytic cells, which is crucial for host defense against pathogens. During activation of NADPH oxidase, NCF1 and NCF2 migrate to the plasma membrane where they associate with cytochrome b558 and the small G protein Rac to form the functional enzyme complex .

  The S370 phosphorylation site is particularly important because it regulates the activation state of NCF1. Phosphorylation at this residue contributes to the conformational changes that allow NCF1 to interact with other components of the NADPH oxidase complex, ultimately leading to enzyme activation and subsequent superoxide production .

• How does S370 phosphorylation differ from other phosphorylation sites on NCF1?

  NCF1 contains multiple phosphorylation sites that regulate its function. While S370 is a key phosphorylation site, other sites like S304 and S359 have also been identified and characterized. Each phosphorylation site may play distinct roles in regulating NCF1 function:

  • S304 phosphorylation is recognized by antibodies like ab63554 and may contribute to NCF1 activation

  • S359 phosphorylation is detected by antibodies like ab74095 and may have unique regulatory roles

  • S370 phosphorylation, the focus of this FAQ, appears to be critical for conformational changes required for NCF1 activity

  These different phosphorylation events likely act in concert to fine-tune NCF1 function in response to various stimuli and cellular contexts. Research suggests these phosphorylation events may occur in a specific sequence or combination to fully activate NCF1 during the respiratory burst in neutrophils.

• What experimental applications are Phospho-NCF1 (S370) antibodies suitable for?

  Based on manufacturer specifications, Phospho-NCF1 (S370) antibodies are suitable for multiple experimental applications:

  • Western Blot (WB): Typically used at dilutions of 1:500-1:2000

  • Immunohistochemistry (IHC): Recommended dilutions around 1:100-1:300

  • Enzyme-Linked Immunosorbent Assay (ELISA): Usually at 1:5000 dilution

  • Some antibodies may also be suitable for immunocytochemistry/immunofluorescence (ICC/IF)

  The specific applications may vary depending on the antibody source and formulation, so it's always advisable to check the manufacturer's datasheet for the recommended applications and dilutions for your specific antibody.

Advanced Research Methodology

• How should I validate the specificity of Phospho-NCF1 (S370) antibody in my research?

  Validating antibody specificity is crucial for ensuring reliable results. For Phospho-NCF1 (S370) antibody, consider these methodological approaches:

  • Phosphatase treatment: Treat half of your sample with lambda phosphatase to remove phosphorylation. A specific phospho-antibody should show reduced or eliminated signal in the treated sample.

  • Peptide competition assay: Pre-incubate the antibody with the synthetic phosphopeptide used as the immunogen (derived from human p47-phox around the phosphorylation site of S370). This should compete away specific binding.

  • Knockout/knockdown controls: Use samples from NCF1 knockout models or cells with NCF1 knockdown to confirm signal specificity.

  • Phosphorylation-inducing treatments: Compare samples from resting cells versus those stimulated with PMA (phorbol 12-myristate 13-acetate) or other activators of the NADPH oxidase pathway, which should increase S370 phosphorylation.

  • Site-directed mutagenesis: Use cells expressing S370A mutant NCF1 (serine to alanine) which cannot be phosphorylated at this position as a negative control.

  These validation steps will help ensure that your observed signals truly represent NCF1 phosphorylated at S370.

• What sample preparation techniques best preserve NCF1 S370 phosphorylation?

  Preserving phosphorylation status during sample preparation is critical:

  • Rapid sample processing: Process tissues or cells as quickly as possible after collection to minimize phosphatase activity.

  • Phosphatase inhibitors: Always include a cocktail of phosphatase inhibitors (e.g., sodium fluoride, sodium orthovanadate, β-glycerophosphate) in your lysis buffers.

  • Cold temperature: Perform all sample preparation steps at 4°C to reduce phosphatase activity.

  • Appropriate lysis buffer: Use a buffer that effectively solubilizes membrane-associated proteins, as NCF1 can translocate to membranes upon activation. RIPA buffer with phosphatase inhibitors is often suitable.

  • Avoid freeze-thaw cycles: Multiple freeze-thaw cycles can degrade phosphoproteins. Aliquot samples before freezing.

  • Protease inhibitors: Include protease inhibitors to prevent degradation of NCF1 protein.

  For storage, it's recommended to keep antibodies at -20°C for long-term storage (up to one year), or at 4°C for short-term storage and frequent use (up to one month), while avoiding repeated freeze-thaw cycles .

• How can I optimize Western blotting conditions for detecting phospho-NCF1 (S370)?

  Optimizing Western blot conditions for phospho-proteins requires special attention:

  • Loading control selection: Use total NCF1 antibody on a separate blot or after stripping, rather than housekeeping proteins alone, to normalize phospho-signal to total protein expression.

  • Blocking optimization: BSA is often preferred over milk for phospho-specific antibodies, as milk contains phospho-proteins that may interfere with detection. The recommended buffer often contains 0.5% BSA .

  • Antibody dilution: Start with the manufacturer's recommended dilution (typically 1:500-1:2000 for WB) and optimize as needed.

  • Incubation conditions: Overnight incubation at 4°C often yields better results for phospho-specific antibodies than shorter incubations.

  • Washing stringency: Use TBS-T rather than PBS-T for phospho-epitopes, as phosphate in PBS may compete with antibody binding.

  • Detection method: Enhanced chemiluminescence (ECL) with longer exposure times may be necessary if the phosphorylation signal is weak.

  • Molecular weight verification: Confirm that the detected band appears at the expected molecular weight of NCF1 (approximately 44-47 kDa) .

Research Applications and Significance

• How does S370 phosphorylation regulate NADPH oxidase assembly and activation?

  The phosphorylation of NCF1 at S370 plays a crucial role in NADPH oxidase activation through several mechanisms:

  • Conformational change: Phosphorylation at S370 contributes to conformational changes in NCF1 that relieve auto-inhibition. In its resting state, NCF1's SH3 domains interact with its autoinhibitory region, preventing interaction with other NADPH oxidase components.

  • Membrane translocation: S370 phosphorylation, along with phosphorylation at other sites, facilitates the translocation of NCF1 from the cytosol to the plasma membrane where it can interact with membrane-bound components of NADPH oxidase.

  • Protein-protein interactions: The phosphorylation-induced conformational changes enable NCF1 to interact with p22phox (part of cytochrome b558) via its SH3 domains and with p67phox (NCF2) through its proline-rich region.

  • Temporal regulation: The timing of S370 phosphorylation likely coordinates with other phosphorylation events to fine-tune NADPH oxidase activation in response to different stimuli.

  The critical role of NCF1 in NADPH oxidase function is highlighted by the fact that mutations in NCF1 are linked to chronic granulomatous disease (CGD), a hereditary immunodeficiency characterized by recurrent bacterial and fungal infections due to defective NADPH oxidase function .

• What role does NCF1 phosphorylation play in disease pathophysiology?

  NCF1 phosphorylation status, including at S370, has significant implications for various disease states:

  • Chronic Granulomatous Disease (CGD): Mutations in NCF1 account for approximately 25% of CGD cases. While most mutations cause protein deficiency, some may affect phosphorylation sites or regions involved in phosphorylation-dependent conformational changes .

  • Inflammatory disorders: Aberrant NCF1 phosphorylation and NADPH oxidase activation can contribute to excessive ROS production and tissue damage in inflammatory conditions.

  • Cancer progression: Recent research using conditional knock-in mouse models expressing functional NCF1 in neutrophils demonstrated that NCF1-competent neutrophils, with their capability for functional ROS induction and IL-1β signaling, can promote tumor lung colonization .

  • Metabolic disorders: Studies using HSF1 phosphorylation-deficient mouse models (with similarities to NCF1 regulation patterns) showed increased susceptibility to obesity with age, suggesting regulatory phosphorylation events may play roles in metabolic homeostasis .

  Understanding the precise role of S370 phosphorylation in these contexts could provide insights into disease mechanisms and potentially identify new therapeutic targets.

• How can I use Phospho-NCF1 (S370) antibody to investigate oxidative stress mechanisms?

  Phospho-NCF1 (S370) antibody can be a valuable tool for investigating oxidative stress mechanisms:

  • Stimulus-response studies: Monitor NCF1 S370 phosphorylation in response to various stressors (e.g., inflammatory cytokines, bacteria, oxidants) to understand activation kinetics.

  • Pharmacological interventions: Evaluate how different inhibitors or activators affect NCF1 phosphorylation to identify upstream regulators.

  • Cell-type specific responses: Compare NCF1 S370 phosphorylation patterns across different cell types (neutrophils, macrophages, etc.) to uncover cell-specific regulatory mechanisms.

  • Disease models: Examine NCF1 phosphorylation status in animal models of diseases associated with oxidative stress (e.g., atherosclerosis, neurodegenerative disorders, diabetes).

  • Co-localization studies: Combine phospho-NCF1 antibody with other markers to track the subcellular localization of phosphorylated NCF1 using immunofluorescence microscopy.

  • Correlation with ROS production: Pair phospho-NCF1 detection with assays measuring superoxide or hydrogen peroxide production to directly correlate phosphorylation status with functional outcomes.

Technical Considerations and Troubleshooting

• What are common troubleshooting strategies for weak or non-specific signals?

  When using Phospho-NCF1 (S370) antibody, several issues may arise:

  Problem	Possible Causes	Solutions
  Weak signal	Insufficient phosphorylation	Ensure appropriate cell stimulation; use positive controls
  	Phosphatase activity during sample preparation	Use phosphatase inhibitor cocktails; keep samples cold
  	Suboptimal antibody concentration	Titrate antibody; try longer incubation times
  	Inappropriate blocking agent	Use BSA instead of milk for phospho-epitopes
  Non-specific bands	Cross-reactivity	Increase washing stringency; optimize antibody dilution
  	Sample overloading	Reduce protein load; titrate primary antibody
  	Inappropriate secondary antibody	Confirm species compatibility; use highly cross-adsorbed secondaries
  No signal	Inadequate exposure	Try longer exposure times; check if protein is expressed
  	Epitope masking	Try different sample preparation methods; consider antigen retrieval for IHC
  	Target protein degradation	Use fresh samples; add protease inhibitors

  For optimal results, keep the antibody at -20°C for long-term storage or at 4°C for short-term use, and avoid repeated freeze-thaw cycles as mentioned in manufacturer guidelines .

• How can I quantitatively analyze NCF1 S370 phosphorylation in response to stimuli?

  Quantitative analysis of NCF1 S370 phosphorylation requires careful experimental design:

  • Western blot quantification:

    • Always run a total NCF1 blot in parallel for normalization

    • Use increasing loads of protein to ensure you're in the linear range of detection

    • Employ digital image analysis software (ImageJ, etc.) for densitometry

    • Express results as the ratio of phospho-NCF1 to total NCF1, normalized to baseline conditions

  • ELISA-based approaches:

    • Consider sandwich ELISA with capture antibody against total NCF1 and detection antibody against phospho-S370

    • Generate a standard curve using recombinant phosphorylated protein

    • Dilution series of samples can help ensure measurements are in the linear range

  • Flow cytometry:

    • For cell-specific analysis, permeabilize cells and stain with phospho-S370 antibody

    • Co-stain with cell-type markers to analyze phosphorylation in specific populations

    • Use median fluorescence intensity for quantification

  • Experimental design considerations:

    • Include time-course experiments to capture phosphorylation kinetics

    • Use appropriate positive controls (e.g., PMA treatment for neutrophils)

    • Consider pharmacological inhibitors to validate signal specificity

  When reporting results, always include both representative images and quantitative data with appropriate statistical analysis.

• What complementary techniques can validate findings from Phospho-NCF1 (S370) antibody studies?

  To strengthen the validity of findings obtained with Phospho-NCF1 (S370) antibody, consider these complementary approaches:

  • Mass spectrometry: Phosphoproteomic analysis can provide unbiased confirmation of S370 phosphorylation and potentially identify other phosphorylation sites that change simultaneously.

  • Functional assays: Measure NADPH oxidase activity (e.g., superoxide production using chemiluminescence or fluorescence-based assays) to correlate phosphorylation with functional outcomes.

  • Mutation studies: Compare wild-type NCF1 with S370A (phospho-deficient) mutants to establish the functional importance of this specific phosphorylation site.

  • Phospho-mimetic approaches: Express S370D or S370E mutants (which mimic phosphorylation) to assess whether constitutive "phosphorylation" at this site affects NCF1 function.

  • Proximity ligation assay: Detect interaction between phospho-NCF1 and other NADPH oxidase components, which can indicate functional relevance of the phosphorylation.

  • In vitro kinase assays: Identify specific kinases responsible for S370 phosphorylation using recombinant proteins.

  • Structural studies: Techniques like hydrogen-deuterium exchange mass spectrometry can reveal how S370 phosphorylation affects NCF1 protein conformation.

  Combining multiple independent techniques provides stronger evidence for the biological significance of S370 phosphorylation in your experimental system.

Experimental Design Strategies

• How should I design experiments to study the kinases responsible for NCF1 S370 phosphorylation?

  To identify and characterize kinases that phosphorylate NCF1 at S370:

  • Kinase inhibitor screening:

    • Treat cells with panel of selective kinase inhibitors (targeting PKC, ERK, p38 MAPK, etc.)

    • Monitor effects on S370 phosphorylation using the phospho-specific antibody

    • Validate hits with dose-response experiments and controls for cell viability

  • Genetic approaches:

    • Use siRNA/shRNA to knock down candidate kinases

    • Employ CRISPR-Cas9 to generate kinase knockout cell lines

    • Overexpress constitutively active or dominant-negative kinase mutants

  • In vitro kinase assays:

    • Synthesize peptides containing the S370 region

    • Incubate with recombinant kinases and ATP

    • Detect phosphorylation using mass spectrometry or radioisotope labeling

  • Co-immunoprecipitation studies:

    • Immunoprecipitate NCF1 from stimulated cells

    • Probe for co-precipitating kinases

    • Perform the reverse IP to confirm interaction

  • Temporal analysis:

    • Compare the kinetics of kinase activation and S370 phosphorylation

    • Sequential inhibition experiments to establish order of events

  Remember that multiple kinases may phosphorylate S370 under different conditions or in different cell types, so results may be context-dependent.

• What considerations are important when using Phospho-NCF1 (S370) antibody in different model systems?

  When applying this antibody across different experimental models:

  • Species cross-reactivity:

    • Confirm antibody reactivity with your species of interest

    • Many Phospho-NCF1 (S370) antibodies react with human, mouse, and rat samples

    • For other species, perform validation experiments before proceeding

  • Cell type considerations:

    • NCF1 expression varies across cell types (highest in neutrophils, also present in macrophages, etc.)

    • Baseline phosphorylation levels may differ between cell types

    • Cell-specific signaling pathways may affect phosphorylation kinetics

  • In vitro vs. in vivo models:

    • Cell culture conditions may affect basal phosphorylation status

    • For in vivo studies, consider tissue-specific extraction protocols to preserve phosphorylation

    • Animal models with NCF1 mutations (like the conditional knock-in model expressing functional NCF1 in neutrophils ) can provide valuable controls

  • Disease models:

    • Consider how disease state may alter NCF1 expression or phosphorylation

    • Include appropriate disease and healthy controls

  • Technical adaptations:

    • Adjust antibody concentration based on expression levels in your model

    • Modify sample preparation based on tissue/cell type (membrane fractionation may be necessary for activated cells)

    • Consider fixation methods carefully for IHC/IF applications in different tissues

  Always perform pilot experiments to optimize conditions for your specific model system before collecting critical data.

• How can I integrate Phospho-NCF1 (S370) antibody studies with broader investigations of NADPH oxidase regulation?

  To place NCF1 S370 phosphorylation in the broader context of NADPH oxidase regulation:

  • Multi-phosphorylation site analysis:

    • Compare phosphorylation at S370 with other sites like S304 and S359

    • Assess temporal relationships between different phosphorylation events

    • Use multiple phospho-specific antibodies to build a comprehensive phosphorylation profile

  • Component interactions:

    • Study how S370 phosphorylation affects NCF1 interaction with other NADPH oxidase components

    • Combine with studies of membrane translocation and complex assembly

    • Consider co-immunoprecipitation or proximity labeling approaches

  • Upstream signaling integration:

    • Connect receptor activation to NCF1 phosphorylation

    • Map signaling cascades that converge on S370 phosphorylation

    • Consider how different stimuli may differentially regulate this phosphorylation

  • Downstream functional consequences:

    • Correlate S370 phosphorylation with superoxide production

    • Investigate effects on pathogen killing, NET formation, or inflammatory responses

    • Consider feedback mechanisms that might regulate phosphorylation status

  • Systems biology approaches:

    • Develop mathematical models of NADPH oxidase activation incorporating S370 phosphorylation

    • Use phosphoproteomics to place NCF1 phosphorylation in broader cellular context

    • Consider cross-talk with other cellular processes (e.g., autophagy, apoptosis)

  This integrated approach will provide a more complete understanding of how S370 phosphorylation contributes to NADPH oxidase regulation in health and disease.